Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Trading Statement

28 Jan 2025 07:00

RNS Number : 8663U
Dialight PLC
28 January 2025
 

FOR IMMEDIATE RELEASE

 

Dialight PLC

28 January 2025

 

Dialight plc ("Dialight" or the "Company")

Q3 trading update

&

Sanmina litigation - settlement discussions

 

Q3 trading update

Trading performance for the 3-month period ended 31 December 2024 was slightly ahead of our expectations. The business traded profitably and generated positive operating cash flow. Group net debt (excluding leases) at 31 December 2024 was $14.8m (30 September 2024: $15.4m). The Board remains confident that further progress will be made during the rest of the financial year.

 

The early Transformation Plan progress reported with the Interim Results in November continued to gain momentum in the third quarter which has allowed us to introduce our 5th Transformation Pillar of creating a platform for future growth. This will provide a strategy and innovation platform for future products and services that, together with the other four pillars, will provide a solid sales and operational base for future, profitable growth. We will also continue to explore opportunities to accelerate our Transformation Plan to focus on delivering our medium-term ambitions.

 

Sanmina litigation - settlement discussions

On 25 September 2024, Dialight announced the details of the jury verdict in the trial relating to the litigation with its former manufacturing partner, Sanmina Corporation (NASDAQ: SANM) (Sanmina) and confirmed that a definitive judgment would be handed down once certain post-trial motions had been filed. Those post-trial motions have now been filed.

 

The Company is pleased to announce that, following constructive discussions with Sanmina, agreement has now been reached in principle to resolve the dispute. Under the settlement terms, Dialight will pay Sanmina $12m in full and final settlement of all claims between the parties. This amount will be paid in instalments, with the first payment of $4m due by 31 March 2025, followed by 8 instalments (the Deferred Instalments) of $1m paid at the end of each subsequent calendar quarter through to 31 March 2027.

 

The amount of any outstanding Deferred Instalments will be automatically increased from $1m to $1.5m if Dialight's market capitalisation exceeds £100m for 30 consecutive days, subject to total cumulative instalment payments not exceeding $8m. A letter has been filed with the New York Southern District court requesting that judgment is deferred pending agreement on a final definitive settlement and the parties will work together to agree a final definitive settlement agreement.

 

The Board is confident that the initial payment of $4m and the Deferred Instalments totalling $8m will be met from the operational cashflow of the business and that the Group has sufficient headroom to meet its ongoing business needs. In the highly remote event of payment default under the settlement agreement following the initial payment, Sanmina will be entitled to enforce the full judgment (less payments already made) in the ordinary course following a 90-day cure period (1).

 

Steve Blair, Dialight CEO, commented: "I am pleased that we have been able to reach a settlement that allows us to put this long running issue behind us. I would particularly like to thank Jure Sola and Jon Faust of Sanmina for their openness and willingness to agree the settlement. Our focus remains on our Transformation Plan for Dialight, for the benefit of all our stakeholders."

 

Note 1: The full judgment, equating to the total claims by Sanmina (as previously disclosed), would amount to $22.9m comprising the jury award of $8.6m, interest of $6.3m and legal costs of $7m.

 

Contacts: 

 

Dialight plc

Tel: +44 (0)203 058 3542

Steve Blair, CEO

Mark Fryer, CFO

 

Investec Bank plc (Financial Adviser and Corporate Broker)

Tel: +44 (0)207 597 5970

Christopher Baird / James Rudd

 

 

Dialight plc

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK with operations in Australia, Dubai, Germany, Malaysia, Mexico, Singapore, the UK and the USA. www.dialight.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFFXALNSEAA
Date   Source Headline
15th Mar 201811:23 amRNSBlock listing six monthly return
14th Mar 201811:36 amRNSDirector/PDMR Shareholding
2nd Mar 201811:02 amRNSPublication of Notice of AGM and form of proxy
26th Feb 20181:01 pmRNSAnnual Financial Report
26th Feb 20187:00 amRNSFull year results 2017
10th Jan 20182:39 pmRNSDirector/PDMR Shareholding
9th Jan 201811:15 amRNSDirector/PDMR Shareholding
8th Jan 20182:40 pmRNSDirector/PDMR Shareholding
8th Jan 20188:24 amRNSDirectorate change,Trading update and outlook
8th Jan 20187:00 amRNSTrading Update and Outlook
20th Dec 201711:17 amRNSHolding(s) in Company
19th Dec 20172:31 pmRNSHolding(s) in Company
18th Dec 20174:44 pmRNSHolding(s) in Company
18th Dec 20173:35 pmRNSHolding(s) in Company
18th Dec 20172:21 pmRNSHolding(s) in Company
14th Dec 20171:36 pmRNSTrading Statement
29th Nov 201711:49 amRNSHolding(s) in Company
6th Nov 20174:09 pmRNSDirector/PDMR Shareholding
2nd Nov 201710:03 amRNSDirector/PDMR Shareholding
26th Oct 201710:27 amRNSHolding(s) in Company
23rd Oct 20177:00 amRNSTrading Update
21st Sep 20173:32 pmRNSTotal Voting Rights
15th Sep 201710:39 amRNSBlock listing Interim Review
14th Sep 20171:08 pmRNSTotal Voting Rights
1st Sep 201710:38 amRNSHolding(s) in Company
23rd Aug 20179:24 amRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSHalf-year Report
5th Jun 20179:06 amRNSDirector Declaration
26th May 201712:06 pmRNSTotal Voting Rights
26th May 20177:00 amRNSNotice of Results
10th May 20172:22 pmRNSTotal Voting Rights
27th Apr 201712:30 pmRNSDirector/PDMR Shareholding
20th Apr 20174:51 pmRNSResolutions passed at 2017 AGM
20th Apr 20177:00 amRNSHolding(s) in Company
13th Apr 20171:02 pmRNSTotal Voting Rights
27th Mar 201710:26 amRNSDirector/PDMR Shareholding
16th Mar 20174:27 pmRNSAnnual Financial Report
15th Mar 201710:57 amRNSBlock listing Interim Review
10th Mar 20174:27 pmRNSDirector/PDMR Shareholding
9th Mar 20179:28 amRNSTotal Voting Rights
6th Mar 20171:45 pmRNSDirector/PDMR Shareholding
27th Feb 20177:00 amRNSFull Year results 2016
22nd Feb 20175:58 pmRNSHolding(s) in Company
7th Feb 201710:11 amRNSTotal Voting Rights
9th Jan 20177:00 amRNSChange of date for 2016 Full Year Results
23rd Dec 20168:59 amRNSTotal Voting Rights
22nd Dec 20164:25 pmRNSDirector/PDMR Shareholding
21st Dec 201612:10 pmRNSDirector/PDMR Shareholding
14th Dec 201610:58 amRNSHolding(s) in Company
14th Dec 201610:54 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.